For SaleMedical
Non-Invasive Substance Concentration Measurement Using an Optical Bridge
US 10,219,755, US 8,175,666 and US 7,003,337, assigned to Valoa Technologies Inc, cover a method for non-invasive measurement of the concentration of target analytes in body tissues, and are available for sale through IPApproach.
- US Patents
- 3 granted
- Assignee
- Valoa Technologies Inc
- Availability
- For Sale
Patents Included
Technology Highlights
- Non-invasive measurement of glucose offers the potential for increased frequency of testing and more responsive control of blood glucose concentrations through concomitant adjustment of insulin doses.
- Non-invasive detection techniques also offer the potential for accurate, portable, closed-loop systems for monitoring and regulating insulin dosage without an indwelling sensor.
- Post-Balancing is done after the measurement data is acquired and analyzed, therefore, it can be tuned to each measurement, and iterated until the required balancing criteria are reached.
- Provides the fastest possible blood content change.
- Provides a good sensitivity to blood.
- Capable of improving accuracy of target analyte concentration estimation.
- Generates the required combined beam without a wavelength-tunable light source.
- The sample provides the advantage of minimizing the effects of the variation in the scattering properties of the sample.
Overview
The technology disclosed provides the following advantages:
Request the Brokerage Marketing Package
Contact Justin Ehrlickman for full documentation, claim charts, and pricing on this opportunity.
Listing updated August 21, 2026
IPApproach lists patents and portfolios where the seller has not requested anonymity or confidentiality. Patent numbers link to public records on Google Patents.